United Therapeutics Corporation (UTHR) — Capital Reinvestment Ratio
United Therapeutics Corporation (UTHR) has a Capital Reinvestment Ratio of 0.37x as of September 2025, meaning it reinvests 0% of its operating cash flow ($562.10 Million) in capital expenditures ($210.50 Million). Check United Therapeutics Corporation tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
United Therapeutics Corporation Capital Reinvestment Ratio (2004–2024)
This chart tracks United Therapeutics Corporation's Capital Reinvestment Ratio across 19 annual periods. For the full cash flow conversion analysis, see United Therapeutics Corporation cash conversion from operations.
Annual Capital Reinvestment Ratio for United Therapeutics Corporation (2004–2024)
Year-by-year Capital Reinvestment Ratio for United Therapeutics Corporation from 2004 to 2024. See United Therapeutics Corporation (UTHR) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.19x | $1.33 Billion | $246.50 Million | ▼ -21.2% |
| 2023 | 0.24x | $978.00 Million | $230.40 Million | ▲ +36.2% |
| 2022 | 0.17x | $802.50 Million | $138.80 Million | ▼ -14.4% |
| 2021 | 0.20x | $598.20 Million | $120.80 Million | ▲ +157.3% |
| 2020 | 0.08x | $755.70 Million | $59.30 Million | ▼ -66.9% |
| 2018 | 0.24x | $778.40 Million | $184.40 Million | ▲ +30.2% |
| 2017 | 0.18x | $474.20 Million | $86.30 Million | ▲ +171.1% |
| 2016 | 0.07x | $643.60 Million | $43.20 Million | ▼ -48.4% |
| 2015 | 0.13x | $382.80 Million | $49.79 Million | ▼ -2.6% |
| 2014 | 0.13x | $355.30 Million | $47.44 Million | ▲ +77.9% |
| 2013 | 0.08x | $425.27 Million | $31.91 Million | ▼ -78.3% |
| 2012 | 0.35x | $323.63 Million | $111.91 Million | ▲ +140.5% |
| 2011 | 0.14x | $250.19 Million | $35.98 Million | ▲ +63.2% |
| 2010 | 0.09x | $211.53 Million | $18.64 Million | ▼ -90.8% |
| 2009 | 0.96x | $99.72 Million | $95.40 Million | ▲ +21.1% |
| 2007 | 0.79x | $48.95 Million | $38.66 Million | ▲ +149.5% |
| 2006 | 0.32x | $49.39 Million | $15.63 Million | ▲ +123.4% |
| 2005 | 0.14x | $43.17 Million | $6.12 Million | ▼ -43.6% |
| 2004 | 0.25x | $20.78 Million | $5.22 Million | — |